Company ProfilePremium

Alfa Ica (India) Limited

Company Profile Analysis

ESOMAR 23 Corporate BadgeISO Certifications Badge
Alfa Ica (India) Limited - Company showcase

Year Founded & Workforce

1991

48 Employees

Alfa Ica (India) Limited logo

Alfa Ica (India) Limited Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Alfa Ica (India) Limited Overview

Alfa Ica (India) Limited is a family-controlled, export-oriented manufacturer of high-pressure decorative laminates (HPL) and compact laminates based in Ahmedabad, Gujarat. Operating from two plants at Sanand with capacity of about 2.1 million sheets a year, the company sells under the "Alfaica" brand, offering a catalogue of more than 600 decors and 50 textures across standard, post-formable, compact, fire-retardant, anti-bacterial, anti-fingerprint, laboratory-grade, exterior and specialty surfaces. Roughly three-quarters or more of sales are exported, chiefly to the UK, Australia, New Zealand, Russia, Israel and Singapore, making the company a niche price-competitive supplier to overseas distributors rather than a domestic consumer brand. With FY2026 revenue of ₹86.6 Cr, net profit of ₹1.9 Cr, a CARE BBB rating and a market value near ₹28 Cr, it is a sub-scale participant in a fragmented industry dominated by Greenlam, Merino and Stylam, competing on breadth of design, European-sourced décor papers and flexibility rather than scale.


What the company does

Alfa Ica manufactures decorative high-pressure laminate sheets and compact laminates. HPL is produced by pressing multiple layers of phenol-resin-saturated kraft paper together with a melamine-resin-impregnated decorative printed paper (and, where required, overlay and underlay papers) under high temperature and pressure. The result is a thin, durable decorative surface used to cover furniture, cabinetry, wall panels, doors, partitions, table and kitchen tops, and, in thicker compact form, as a self-supporting panel for washroom cubicles, laboratory worktops, lockers, exterior cladding and similar high-wear applications (company product descriptions as summarised by Kotak Securities, IIFL and Investing.com).

The company's own description (as reproduced in its annual reports and directors' reports, FY2025) emphasises that the Alfa range comprises more than 600 design decors and more than 50 textures, and that the laminates are recognised by architects, interior designers and fitters. Its marketing positions all decorative papers as sourced from premier European printers and its products as conforming to the EN 438 European HPL standard (Groww company profile, citing company disclosures). The company describes itself as a Government-recognised Star Export House holding ISO 9001 and ISO 14001 certifications (CARE Ratings, Dec 2025).

Business and revenue model

DimensionCharacterisationEvidence
Revenue type~100% product sales (manufactured laminate sheets and compacts); no service, subscription or licensing revenue disclosedSingle-line revenue in results; no segment reporting (Sharpely, Screener)
Sales mix by geographyExports ~78% of gross sales (FY2025), ~77% (FY2024), ~75% (FY2023)CARE Ratings Dec 2025
Export incentives / other operating revenue"Revenue as reported" exceeds operating revenue by ~₹0.9–2.0 Cr p.a., consistent with export incentives and other operating incomeStockAnalysis.com (S&P) FY2022–FY2026
Brand"Alfaica"CARE Ratings
Customer typesOverseas importers/distributors of surfacing materials, furniture and fit-out fabricators, domestic dealers; architects and interior designers as specifiersCARE Ratings; company descriptions; Panjiva (US importer Decotone Surfaces)
End-marketsResidential furniture and interiors, commercial interiors (offices, shops), institutional (schools – chalk/marker boards; hospitals – anti-bacterial; laboratories), washrooms/cubicles, exterior façadesInvesting.com company description
Value-chain positionMid-stream converter: buys imported kraft and décor papers plus melamine and phenol/formaldehyde chemicals; sells finished sheets to distributionCARE Ratings Dec 2025
ProcurementImports ≈40% of raw material cost (kraft and décor papers, melamine); paper lead times 2–6 months, forcing high inventoriesCARE Ratings Dec 2025
HedgingNatural hedge as net exporter; no active FX hedging policyCARE Ratings Dec 2025

Independent characterisation

Alfa Ica is best understood as a contract-style, export-led, design-breadth manufacturer operating at the small end of the Indian laminate industry. Its economic engine is the spread between export realisations (largely USD/GBP/AUD-linked) and the cost of imported paper and petrochemical-derived resins, minus the carrying cost of a large, slow-turning paper inventory. Unlike Greenlam or Merino, which invest heavily in domestic brand-building, dealer networks and showroom formats, Alfa Ica's distribution is concentrated among a limited number of overseas buyers. This structure explains three persistent features of its financials: (i) thin EBITDA margins of roughly 5–6.5% (versus 11–19% for the listed leaders); (ii) a long cash conversion cycle of 100–155 days; and (iii) meaningful sensitivity of reported profit to foreign-exchange gains, which have frequently represented a large share of pre-tax profit (S&P data show FX gains of ₹0.84 Cr in FY2025 and ₹1.94 Cr in FY2026 against PBT of ₹1.92 Cr and ₹2.54 Cr respectively).

The business is also exposed to credit risk at the customer level: in FY2025–FY2026 the company had to write off most of a ₹2.68 Cr receivable from International Decorative Surfaces, a UK distributor that entered administration (CARE Ratings, Dec 2025). Given annual net profit of only ₹1.4–1.9 Cr, a single customer failure of that magnitude can eliminate more than a year of earnings.

Strategy

Stated strategy

The company does not publish a formal strategy document, investor-day material or medium-term targets. Themes recurring in its annual reports and directors' reports include: (i) continuous introduction of new designs and finishes to serve interior decorators and furniture designers; (ii) maintaining quality certifications (ISO 9001, ISO 14001) and export-house status; (iii) sourcing décor papers from premier European printers to meet EN 438; and (iv) prudence in capital allocation, historically expressed as conserving resources rather than paying dividends.

Inferred strategic initiatives (last 24 months)

InitiativeEvidenceStatus / assessment
Capacity/plant investmentCapex of ~₹5.0 Cr in FY2025, net fixed assets +₹4.4 Cr; CWIP of ₹0.76 Cr at FY2024 capitalisedCompleted; depreciation up 36% in FY2025
Brand and marketing investmentAdvertising expense rose from ₹0.10 Cr (FY2023) to ₹0.78 Cr (FY2025) and ₹0.68 Cr (FY2026) (S&P)Ongoing; ~0.8% of revenue
Product-mix upgrade toward compacts and specialty gradesCARE (2019) cited higher share of thick laminates; portfolio now includes cubicle compacts, exterior façades, fire-retardant, lab-gradeOngoing
Leadership formalisationMD/JMD re-designations (Oct 2025)Completed
Working-capital tighteningCCC cut from 155 to 102 days (FY2023–FY2026)Delivered
Credit-risk management after UK distributor failure~60% of ₹2.68 Cr written off; balance to be written offIn progress

Sustainability, cost programmes, guidance

No ESG targets, formal cost-reduction programmes, partnerships or new business launches have been announced. Management guidance: none published. The only forward-looking benchmarks available are CARE's rating sensitivities — upgrade triggers of sustained PBILDT margins above 10% and net worth above ₹75 Cr; downgrade triggers of an operating cycle above 125 days, PBILDT interest coverage below 2.5x or TD/PBILDT above 3x.

Products & Services

All products sit within the single laminates segment and are sold under the Alfaica brand. The company does not publish prices, launch years or version histories; these are marked accordingly.

Sources: Simply Wall St and Investing.com company descriptions (S&P / Refinitiv profiles); Kotak Securities / IIFL company summaries; Groww profile; CARE Ratings.

Portfolio observations. Breadth is the principal selling proposition: >600 decors is comparable to larger domestic players' catalogues and is vital for export distributors who need range depth. CARE noted as early as Dec 2019 that a rising share of higher-value thick laminates lifted margins in FY2019, implying a strategic tilt toward compacts and specialty grades. Notably absent from the portfolio (versus Greenlam/Stylam) are plywood, particle board, veneers, engineered wood flooring, solid surfaces, PU-lacquer-coated panels and acrylic/PVC laminates — limiting cross-selling opportunities.

Product Portfolio

Product lineDescription / key capabilitiesTypical applications / target customerLaunch yearPricing model

Standard decorative HPL (general purpose)

Multi-layer phenolic kraft core with melamine-impregnated décor paper; >600 decors, >50 textures; produced to EN 438

Furniture covering, cabinets, wardrobes, doors, wall panelling; furniture makers, distributors

Core product since inception

Not disclosed (per-sheet distributor pricing typical)

Post-formable laminates

Thinner grade engineered to bend around rounded edges under heat; company material indicates post-forming capability up to about 3 mm radius-type applications

Kitchen counter edges, rounded table tops, furniture edges

——

Compact grade laminates

Thick self-supporting HPL with décor on both faces; usable for horizontal and vertical applications without substrate

Table tops, partitions, furniture panels, institutional fit-outs

——

Cubicle compact / cubicle partition panels

Moisture-resistant compact panels for washroom and changing-room cubicles

Commercial washrooms, schools, gyms, malls

——

Colour core / colour compact laminates

Through-coloured core so that machined edges show matching colour

Premium furniture, retail fixtures

——

Interior grade and exterior grade (façade) laminates

Exterior grade engineered for weather and UV resistance; offered as exterior façade/cladding panels

Building façades, exterior wall cladding; architects, façade contractors

——

Interior tile panels

Decorative laminate-faced tile/panel formats for walls

Interior wall panelling in commercial spaces

——

Tough gloss laminates

High-gloss, scuff-resistant range

Shops, offices, homes — premium display surfaces

——

Anti-fingerprint laminates

Matte super-surface resisting fingerprint marks

Kitchens, premium furniture

——

Anti-bacterial laminates

Surfaces treated to inhibit bacterial growth

Hospitals, clinics, kitchens, hygiene-sensitive areas

——

Laboratory grade laminates

Chemical-resistant surfaces

School/industrial/medical laboratory worktops

——

Fire retardant laminates

Formulated to meet fire-performance requirements

Public buildings, transport interiors, hotels

——

Flooring grade laminates

High wear-resistance grade

Flooring applications

——

Real metal foil laminates

Laminates surfaced with real metal foils giving metallic lustre

Retail and hospitality feature walls, furniture accents

——

Dry wipe / white marker boards

Writable laminate surfaces

Schools, offices

——

Green chalk board laminates

Chalk-writable laminate surfaces

Schools and colleges

——

Shower panels / wet-area panels

Moisture-resistant panels

Bathrooms, wet areas

——

“—” = not publicly disclosed.

Financial Narrative

Primary source: Screener.in standalone financials compiled from BSE-filed audited results (FY2022–FY2026); supplementary data from StockAnalysis.com (S&P Global Market Intelligence, last updated 8 Aug 2026). Ratios marked "computed" are analyst calculations from these figures.

Income statement

Note on gross profit: S&P's "cost of revenue" includes only materials consumed; the FY2026 figure was restated from ₹34.20 Cr to ₹33.47 Cr between two S&P data snapshots. Gross margin should be read as a materials-spread indicator, not a conventional gross margin.

Margin profile

CARE's PBILDT margin is computed on total operating income (incl. export incentives) and differs from Screener's operating margin (which excludes other operating income); FY2024–FY2025 CARE values shown for reference.

Revenue CAGR: FY2022–FY2026 (4-year) = 2.0%; FY2021–FY2026 (5-year, from ₹55.17 Cr) = 9.45%; 10-year (Screener) = 6%. TTM to June 2026: ₹96.77 Cr, +23%.

Commentary — income statement. The five-year record shows a business with volatile top-line but remarkably stable absolute earnings. Revenue swung from a pandemic-restocking peak of ₹80 Cr in FY2022 to ₹65 Cr in FY2023, then recovered for three consecutive years to a new high of ₹86.6 Cr in FY2026; the trailing twelve months to June 2026 reached ₹96.8 Cr after a record Q1 FY2027 (₹29.72 Cr). Yet absolute EBITDA has been trapped in a ₹4.0–4.4 Cr band throughout, meaning incremental revenue has delivered almost no incremental operating profit. The operating margin compressed from 6.3% in FY2023 to 4.8% in FY2026, and to 4.4% on a TTM basis, despite S&P's materials spread widening to ~39–41%. The explanation lies in the "other operating expenses" line, which rose from ₹17.4 Cr (FY2023) to ₹26.1 Cr (FY2026) per S&P — consistent with higher power, freight, employee and selling costs, and with a step-up in advertising from ₹0.10 Cr (FY2023) to ₹0.78 Cr (FY2025) and ₹0.68 Cr (FY2026).

Below EBITDA, two forces offset each other: interest cost rose by 27% from FY2024 to FY2025 as working-capital borrowings increased, and depreciation jumped 36% after the FY2025 capex; but other income — dominated by foreign-exchange gains as the rupee weakened — more than doubled to ₹1.94 Cr in FY2026. The quality-of-earnings conclusion is important: in FY2026, other income equalled 76% of PBT. Excluding FX, the core business would have earned a pre-tax profit of roughly ₹0.6 Cr. Net profit growth of 32% in FY2026 was therefore largely currency-driven rather than operational.

Quarterly trajectory (last 9 quarters)

Source: Screener.in (BSE quarterly results). Discrepancy note: one news aggregator (ScanX) reported Q1 FY2027 net profit of ₹1.02 Cr on revenue of ₹30.08 Cr; the company's standalone filing as relayed by Capital Market and ScanX's own second article show net profit of ₹76.56 lakh on revenue from operations of ₹2,972.02 lakh. The ₹0.77 Cr figure is adopted as primary.

Quarterly commentary. The last three quarters mark a clear volume inflection — sales rose from ₹19 Cr in Q2 FY2026 to ₹22 Cr, ₹26 Cr and ₹30 Cr — but margins have not followed. Q4 FY2026 was particularly weak at the operating line (OPM 1.97%), rescued by ₹1.10 Cr of other income. Q1 FY2027 returned to a 5% OPM. Whether the revenue surge reflects new export customers, price increases passed through on resin inflation (larger peers implemented 12–15% laminate price hikes in FY2026 per Greenlam's commentary), or a one-off order is not disclosed.

Balance sheet

Items not separately disclosed in reviewed sources: cash and cash equivalents at each year-end (CARE reports only ₹0.59 Cr at 30 Sep 2025; Screener's annual net cash flows of between −₹0.13 Cr and +₹0.25 Cr imply cash balances consistently below ₹1 Cr); short-term vs long-term debt split (CARE indicates borrowings are predominantly fund-based working-capital facilities — cash credit/packing credit of ₹12 Cr sanctioned — plus unsecured loans from promoters and relatives, with nil scheduled term-debt repayment); and working capital in absolute terms. Given negligible cash, net debt ≈ gross borrowings (₹16.8 Cr at FY2026).

Cash flow

Source: Screener.in cash-flow statements (BSE annual reports). CARE separately reports FY2025 CFO of ₹1.96 Cr (vs Screener ₹1.87 Cr — minor classification difference).

Commentary — cash flow. Cash generation alternates with the working-capital cycle: years of revenue acceleration (FY2022, FY2025) consume cash as inventory and receivables build, while years of stabilisation (FY2023, FY2024, FY2026) release it. Cumulative five-year FCF is +₹4.6 Cr against cumulative net profit of ₹8.1 Cr — a 57% conversion, reflecting the capital intensity of carrying imported paper stock. FY2025 was the heaviest investment year in the period (₹5.0 Cr capex, lifting net fixed assets by 29%), funded by incremental borrowings of ₹5 Cr; FY2026 FCF of ₹4.0 Cr was used to repay ₹2.2 Cr of debt and fund interest. The company has paid no dividend since FY2019 and has never conducted a buyback.

Ratio analysis

Current ratio: not publicly disclosed in reviewed sources (the current-asset/current-liability split was not available; CARE describes liquidity as "adequate" with ~70% average utilisation of working-capital limits over the 12 months to Oct 2025). Ratios use Screener inventory-day conventions; CARE computes FY2025 operating cycle at 103 days (inventory 79, collection 51) versus 111 days in FY2024 — methodology differs.

Commentary — ratios. Returns are structurally below the cost of equity: ROE of 6–9% and ROIC of 7–8% compare unfavourably with an Indian small-cap cost of equity in the low-to-mid teens, which is consistent with the stock trading close to book value (P/B ~1.1x). The single most encouraging trend is the cash conversion cycle, which has shortened from 155 days (FY2023) to 102 days (FY2026), driven by lower inventory days and stretched payables — an important improvement given CARE's negative rating trigger of an operating cycle above 125 days. Leverage metrics, however, sit uncomfortably close to CARE's other negative triggers: CARE's own PBILDT interest coverage fell to 2.59x in FY2025 and 2.40x in H1 FY2026, already below the 2.5x downgrade sensitivity, while gross debt/EBITDA on Screener data (4.1x) exceeds the agency's 3x threshold (though CARE's definition of debt is narrower).

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Revenue by Segment and Segment Margins & Growth (%)

Segment (INR Cr)FY2024FY2025FY2026

Decorative laminates – revenue from operations

68.4978.5686.64

Decorative laminates – operating profit (EBITDA, excl. other income)

4.064.434.14

Decorative laminates – profit before tax

2.231.922.54

Operating (EBITDA) margin %

5.935.644.78

YoY revenue growth %

5.9614.7010.29

Contribution to total revenue %

100100100

Income Statement and Margin Analysis (%)

MetricFY2022FY2023FY2024FY2025FY2026

Revenue from operations (INR Cr)

79.9864.6468.4978.5686.64

Revenue growth YoY (%)

44.96-19.195.9614.7010.29

Gross profit – S&P definition (INR Cr)

28.7423.9126.1831.8633.47

Operating profit / EBITDA excl. other income (INR Cr)

4.394.074.064.434.14

Other income incl. FX gains (INR Cr)

0.400.550.800.881.94

Depreciation (INR Cr)

1.011.040.991.351.46

EBIT = PBT + interest (INR Cr, computed)

3.783.583.873.964.62

Interest expense (INR Cr)

1.591.631.642.042.08

Profit before tax (INR Cr)

2.191.952.231.922.54

Tax rate (%)

25.5725.1324.6625.0025.59

Net profit (INR Cr)

1.631.461.681.441.90

EPS basic (INR)

4.033.614.163.564.70

EPS diluted (INR)

4.033.614.163.564.70

Dividend per share (INR)

00000

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Margin Analysis (%)

MetricFY2022FY2023FY2024FY2025FY2026

Gross margin – S&P (%)

35.9336.9938.2340.5638.63

EBITDA margin excl. other income (%)

5.496.305.935.644.78

EBIT margin incl. other income (%, computed)

4.735.545.655.045.33

Pre-tax margin (%)

2.743.023.262.442.93

Net margin (%)

2.042.262.451.832.19

CARE PBILDT margin (%)

——7.016.64—

Income Statement and Margin Analysis (%) (Quarterly)

Metric (INR Cr)Q1FY2025Q2FY2025Q3FY2025Q4FY2025Q1FY2026Q2FY2026Q3FY2026Q4FY2026Q1FY2027

Sales

19.5118.4220.2620.3719.5918.9822.1725.9029.72

Operating profit

1.301.290.051.711.311.061.160.511.51

OPM (%)

6.667.000.258.396.695.585.231.975.08

Other income

0.000.180.180.510.210.370.271.100.36

Interest

0.420.530.550.440.500.490.550.450.46

Depreciation

0.300.340.350.360.360.360.360.380.38

PBT

0.580.60-0.671.420.660.580.520.781.03

Net profit

0.420.48-0.541.080.500.450.390.560.77

EPS (INR)

1.041.19-1.342.671.241.110.971.391.91

Balance Sheet and Per-Share Data

Metric (INR Cr)FY2022FY2023FY2024FY2025FY2026

Total assets

44.9140.0044.5948.5352.59

Net fixed assets

13.7114.4315.1619.5719.92

Capital work in progress

0.000.000.760.000.00

Other (mainly current) assets

31.2025.5728.6728.9632.67

Goodwill & intangibles

00000

Equity share capital

4.044.044.044.044.04

Reserves

14.5716.0517.7319.1821.09

Total shareholders' equity

18.6120.0921.7723.2225.13

Total borrowings

17.4414.9814.0419.0016.84

Other liabilities (incl. trade payables)

8.864.938.786.3110.62

Book value per share (INR, computed)

46.0649.7353.8957.4862.20

Cash Flow and Margin Analysis (%)

Metric (INR Cr)FY2022FY2023FY2024FY2025FY2026

Cash from operating activities

-1.345.755.211.875.85

Capital expenditure (computed = CFO − FCF)

1.731.762.494.981.82

Free cash flow

-3.073.992.72-3.114.03

Cash from investing activities

-1.73-1.75-2.48-4.96-1.81

Cash from financing activities

3.11-4.02-2.473.03-4.17

Net change in cash

0.04-0.030.25-0.06-0.13

Dividends paid

00000

Share buybacks

00000

CFO / operating profit (%)

-1715214052152

Returns & Leverage Ratios (%) and Financial Ratios (x)

RatioFY2022FY2023FY2024FY2025FY2026

ROE (%, net profit / average equity, computed)

9.167.558.036.407.86

ROA (%, net profit / average assets, computed)

3.953.443.973.093.76

ROCE (%, Screener)

11.6610.0710.9810.1011.00

ROIC (%, NOPAT / period-end equity + debt, computed)

7.797.648.137.048.19

Debt / equity (x, Screener basis)

0.940.750.640.820.67

Overall gearing (x, CARE basis)

——0.340.50—

Gross debt / EBITDA (x, computed)

3.973.683.464.294.07

Interest coverage – EBIT / interest (x, computed)

2.382.202.361.942.22

PBILDT interest coverage (x, CARE)

——2.972.59—

Asset turnover (x, revenue / average assets)

1.941.521.621.691.71

Debtor days

56.9542.2451.9155.9457.00

Inventory days

117.58144.93138.29107.49102.41

Payable days

53.7532.0757.1436.8357.09

Cash conversion cycle (days)

120.79155.09133.06126.60102.32

Working capital days

48.4765.1161.8751.0649.08

Revenue by Region (%) and Revenue by Region

MetricFY2023FY2024FY2025

Export share of gross sales (%, CARE)

757778

Export revenue (INR Cr)

—51.6159.59

Domestic share of gross sales (%, derived)

252322

Region Overview

RegionCountries namedSource

Europe

United Kingdom (key market; also site of the insolvent distributor International Decorative Surfaces), Russia

CARE Dec 2025

Middle East

Israel

CARE Dec 2025

Asia-Pacific

Australia, New Zealand, Singapore

CARE Dec 2025; ICICI Direct profile

Americas

United States (US importer Decotone Surfaces appears in US customs bills of lading 2019 and 2023; a ₹0.34 Cr receivable from a US-based entity was overdue >6 months as of Dec 2025)

Panjiva; CARE Dec 2025

India (domestic)

Not broken down by state

—

Capital Markets

MeasureValueSource

Last close

₹70.10 (16 Oct 2026)

StockAnalysis.com

52-week high / low

₹101 / ₹67.8

Screener.in (30 Sep 2026)

1-year return

−10% (to 30 Sep 2026)

Screener.in

3-year price CAGR

12%

Screener.in

5-year price CAGR

17%

Screener.in

10-year price CAGR

8%

Screener.in

Average weekly volatility

11.7% vs 5.3% market average

Simply Wall St

Trading venue / liquidity

BSE X-group; very thin volumes

MarketsMojo; BSE

Per-Share Data

MetricFY2022FY2023FY2024FY2025FY2026

Book value per share (INR)

46.0649.7353.8957.4862.20

EPS (INR)

4.033.614.163.564.70

Dividend payout (%)

00000

Valuation Multiples

MultipleAlfa IcaBasis

Market capitalisation

≈ ₹28.3 Cr

4.04 M shares

Enterprise value

≈ ₹44.6–45.1 Cr

Market cap + FY2026 borrowings ₹16.84 Cr − cash (<₹0.6 Cr assumed per CARE Sep 2025)

P/E (TTM EPS ₹5.38)

≈ 13.0x

Screener TTM to Jun 2026

P/E (FY2026 EPS ₹4.70)

≈ 14.9x

—

P/B (BV ₹62.2)

≈ 1.13x

FY2026

EV/EBITDA (TTM EBITDA ≈ ₹4.24–4.26 Cr)

≈ 10.5x

Screener/S&P TTM

EV/Sales (TTM ₹96.8 Cr)

≈ 0.46x

—

Dividend yield

0%—

Dividend History

YearDividend payout ratioImplied DPS

FY2015–FY2017

0%

Nil

FY2018

34.24%

≈ ₹1.0 (derived from EPS ₹2.92; not company-confirmed)

FY2019

32.32%

≈ ₹1.0 (derived from EPS ₹3.09; not company-confirmed)

FY2020–FY2026

0%

Nil

Analyst Conclusions

Management guidance and consensus

Management provides no financial guidance, and there is no analyst consensus. The nearest forward indicators are: (i) the run-rate of the last three quarters (₹22.2 Cr → ₹25.9 Cr → ₹29.7 Cr), which annualises above ₹100 Cr; (ii) CARE's stable outlook, premised on experienced promoters and the established Alfaica brand; and (iii) industry growth of ~4–5% p.a. in both Indian and global HPL markets.

Bull case

  1. Volume breakout with operating leverage. Q1 FY2027 revenue of ₹29.72 Cr (+52%) implies the company may be winning new export accounts or share; if EBITDA margin merely returns to the FY2023 level of 6.3% on ₹110 Cr of revenue, EBITDA would reach ~₹7 Cr — 65% above the five-year plateau — with net profit potentially exceeding ₹3.5 Cr (EPS ~₹9), making the current ₹70 price ~8x forward earnings.

  2. Balance sheet discipline improving. The cash conversion cycle fell 53 days in three years and FY2026 FCF of ₹4.0 Cr allowed ₹2.2 Cr of debt reduction; continued improvement would lift coverage back above CARE's 2.5x threshold and lower interest costs.

  3. Asset-backed valuation. At ~1.1x book and ~0.46x EV/sales, the stock prices in near-zero growth; the FY2025 capex has been absorbed, depreciation is stable at ~₹1.5 Cr, and promoter ownership of 71% aligns management with minority holders.

Bear case

  1. Growth without profit. Absolute EBITDA has been flat at ₹4.0–4.4 Cr for five years; FY2026 OPM fell to 4.8% and Q4 FY2026 to 2.0%. The revenue surge may be price-led pass-through of resin inflation rather than real volume, with no margin benefit.

  2. Low-quality earnings. FX gains accounted for ~76% of FY2026 PBT; a stable or appreciating rupee would cut reported profit by more than half. Simultaneously, CARE coverage of 2.40x is already below the downgrade trigger.

  3. Customer and governance risk. A single UK distributor failure wiped out more than a year's profit; exposure to Russia and Israel adds tail risk. Two Company Secretary changes in 13 months, a 44% unexplained drop in shareholder count, and MD pay increases with no dividend for seven years weigh on minority-investor confidence.

Key catalysts and monitorables (next 12 months)

Catalyst / monitorableTimingWhat to watch
Q2 FY2027 results~Nov 2026Whether ₹25–30 Cr quarterly revenue sustains; OPM recovery toward 6%+
CARE annual surveillance~Dec 2026Rating retention given coverage below 2.5x; any outlook change
Write-off of remaining UK receivable (~₹1.1 Cr)FY2027Size and timing of residual charge
INR/USD, INR/GBP, INR/AUD movementsContinuousFX gain/loss contribution to other income
Resin, melamine, kraft paper pricesContinuousGross spread and pass-through
Capacity announcementsAnyExpansion beyond 21 lakh sheets would signal confidence in demand
Shareholder register / governanceQuarterlyExplanation for shareholder-count drop; CS stability; any dividend resumption
Q3 FY2027 and FY2027 resultsFeb 2027; May 2027Full-year revenue >₹100 Cr and EBITDA >₹5 Cr would break the multi-year plateau

Analyst verdict

Alfa Ica (India) Limited is a durable but structurally low-return niche exporter. Its thirty-five-year survival, unbroken record of annual profits, broad design library and export-house credentials demonstrate genuine operational competence; few Indian micro-cap manufacturers have navigated the global financial crisis, COVID and successive raw-material cycles without a loss year. Yet the financial record also shows a company that has not converted that competence into economic value. Revenue grew at about 9% a year over FY2021–FY2026, but absolute EBITDA did not grow at all, returns on equity have stayed in single digits, and in FY2026 the majority of pre-tax profit came from currency gains rather than the laminate business itself.

The recent revenue acceleration — a record ₹29.7 Cr in Q1 FY2027, with trailing revenue near ₹97 Cr — is the most important development in years and is the hinge of any investment case. If it reflects durable new export volume and the company can restore 6–7% EBITDA margins, earnings could roughly double and the shares, at ~13x trailing earnings and ~1.1x book, would look inexpensive. If instead it reflects price pass-through or a lumpy order, the margin data already suggest the extra revenue will not reach the bottom line.

Credit metrics argue for caution: CARE interest coverage sits below its own downgrade trigger, debt equals about four times EBITDA, and a single distributor insolvency in the UK erased more than a year of profit. Governance — family control, rising executive pay, no dividends since FY2019, frequent Company Secretary turnover and an unexplained halving of the shareholder register — warrants scrutiny. Extreme illiquidity further limits institutional suitability.

Verdict: a speculative, deep-value micro-cap whose re-rating depends entirely on proving that its new revenue run-rate carries margin. Monitor Q2 and Q3 FY2027 OPM and the December 2026 CARE review before forming a constructive view; absent margin improvement, the stock merits a neutral-to-cautious stance.


APPENDIX A — DATA DISCREPANCIES NOTED

ItemSource ASource BTreatment
Q1 FY2027 net profit₹0.77 Cr (₹76.56 lakh; Capital Market, ScanX article 2)₹1.02 Cr (ScanX headline)₹0.77 Cr adopted (matches standalone filing figures)
FY2024 export share~77% of gross sales (CARE)75.35% (₹51.61 Cr; Groww/company)Both shown; denominator difference likely
Leverage FY2025D/E 0.82x (Screener)Gearing 0.50x (CARE)Both shown; CARE likely treats promoter loans as quasi-equity
FY2025 CFO₹1.87 Cr (Screener)₹1.96 Cr (CARE)Screener used in tables
FY2026 gross profit (S&P)₹34.20 Cr (earlier snapshot)₹33.47 Cr (later snapshot)Later figure used
Operating cycle FY2025CCC 126.6 days (Screener)103 days (CARE)Both shown; methodology differs
Shyamal Raval classificationNon-Executive DirectorIndependent Director (one extract)Flagged as inconsistent
Q3 FY2026 board meeting date5 Feb 2026 (Screener)6 Feb 2026 (Value Research intimation)5 Feb 2026 used (outcome date)
BSE listing dateOct 2004 (S&P data)IPO date not disclosed—

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Executive Leadership Team

NameTitleTenure / key datesBackgroundAgeCompensation

Rishi Tikmani (DIN 00638644)

Managing Director (from 1 Oct 2025; previously Whole-time / Executive Director)

Executive Director since at least 2009; re-appointed 2012; MD term 1 Oct 2025 – 30 Sep 2028

Son of founder Rajendra Tikmani; BBA (Gujarat University) and MBA in International Business; >10 years' experience per CARE

43 (per Aug 2025 BSE filing)

Total ₹5.4 M (FY2024, S&P via Simply Wall St); ₹5.4 M director remuneration also recorded in FY2020 related-party note; increase approved at Sep 2026 AGM effective 1 Aug 2026 (amount not disclosed in reviewed sources)

Pooja Tikmani (DIN 06944249)

Women Joint Managing Director (from 1 Oct 2025; previously Woman Executive Director)

Joined as Purchase Manager (2009); director since at least FY2019; JMD term 1 Oct 2025 – 30 Sep 2028

Daughter of founder; sister of Rishi Tikmani; oversees purchasing/operations

43 (per Aug 2025 BSE filing)

₹5.4 M director remuneration recorded in FY2020; current not disclosed; increase approved Sep 2026

Hansraj Sekhani

Chief Financial Officer

CFO since at least FY2019

———

Himadri Trivedi

Company Secretary (May 2019 – Sep 2025)

Appointed 9 May 2019; resignation filed 30 Sep 2025

———

Dhara Mistry

Company Secretary & Compliance Officer (Sep/Oct 2025 – Oct 2026)

Resignation considered at 3 Oct 2026 board meeting

———

Himandri Shah

Company Secretary & Compliance Officer (appointment considered 3 Oct 2026)

New appointee

———

“—” = not publicly disclosed.

Board of Directors

DirectorCategoryNotes

Rishi Tikmani

Executive – Managing Director (promoter)

Member of board committees

Pooja Tikmani

Executive – Women Joint Managing Director (promoter)

Retired by rotation and re-appointed at 2025 AGM

Shyamal Raval

Non-Executive Director (appointed FY2025)

Retired by rotation and re-appointed at 35th AGM (21 Sep 2026); one extract describes him as Independent — classification inconsistent across sources

Ayush Kedia

Independent Director

Chairs a board committee (likely Audit or Nomination & Remuneration)

Poonam Panchal

Independent Director (appointed FY2025)

Committee member

Board & Management Changes

DateChangeContext

FY2025

Appointment of Shyamal Raval (NED) and Poonam Panchal (ID)

Board refresh replacing long-tenured IDs

23 Aug 2025 (effective 1 Oct 2025)

Rishi Tikmani re-designated MD; Pooja Tikmani re-designated Women JMD, both for three years

Formalises second-generation leadership

30 Sep 2025

CS Himadri Trivedi resigns; successor appointed

Routine KMP change

21 Sep 2026

AGM approves higher remuneration for both MDs from 1 Aug 2026

Follows FY2026 profit recovery

3 Oct 2026

CS Dhara Mistry resigns; Himandri Shah appointed

Second CS change in ~12 months

Major Shareholders

Holder categoryJun 2026 stake (%)Trend

Promoter & promoter group (Tikmani family)

71.12

Unchanged since FY2019 (rose from 68.27% in FY2017)

Foreign institutional investors

0.00—

Domestic institutional investors

0.05

Unchanged since at least FY2017

Public / retail & others

28.82

Stable

Number of shareholders

3,077

Fell from 5,665 (Sep 2025) to 3,172 (Dec 2025) — a 44% drop in one quarter without a corresponding change in public float; reason not disclosed (possibly folio consolidation or reclassification of physical holdings)

Competitive Landscape

Key Competitors

CompetitorListingRelevanceLatest revenue / scalePositioning vs Alfa Ica

Greenlam Industries

NSE/BSE

Market leader; among top three global laminate makers

FY2026 consolidated revenue ₹3,046 Cr; laminates & allied ₹2,433 Cr; net profit ₹56.0 Cr

~35x Alfa's revenue; strong domestic brand, global distribution, diversified into plywood and chipboard

Stylam Industries

NSE/BSE

Export-led laminate specialist — closest business-model peer

FY2026 total income ₹1,136 Cr; PAT ₹150 Cr; third plant in Panchkula commencing 2026

~13x Alfa's revenue; far superior margins (Q1 FY2026 EBITDA margin 18.7%); zero debt

Merino Laminates (Merino Industries)

Unlisted

Large domestic and export HPL maker

Not publicly disclosed in reviewed sources

Scale and brand leader

Royale Touche

Unlisted

Premium domestic laminate brand, strong in 1.25 mm segment

—

Premium positioning

Century Plyboards (Century Laminates)

NSE/BSE

Laminates segment within diversified wood panels group

—

Distribution scale

Archidply Decor

BSE

Small listed decorative laminate peer

—

Comparable micro-cap

Bloom Dekor

BSE

Small listed laminate peer

—

Comparable micro-cap

Deco-Mica

BSE

Small listed laminate peer (Gujarat)

—

Comparable micro-cap

Duroply Industries

BSE

Plywood/laminates

—

Domestic brand

Wilsonart, Formica, Abet Laminati, EGGER, Kronospan, Pfleiderer, Arpa

International

Global HPL/compact competitors in Alfa's export markets

Global scale

Alfa competes as lower-cost Indian supplier

“—” = not publicly disclosed.

Peer Comparison FY2026

MetricAlfa IcaGreenlam IndustriesStylam Industries

Revenue / total income (INR Cr)

86.6

3,046.1 (consolidated)

1,136.1 (total income)

Revenue growth YoY (%)

10.318.6

~10.0 (total income)

EBITDA margin (%)

4.8 (excl. other income)

~11.0 (EBITDA before forex & exceptional ₹334.2 Cr)

—

Net margin (%)

2.21.8

~13.2

Net debt

≈ ₹16.8 Cr

₹940 Cr

Zero debt (per Q1 FY2026 disclosure)

Export orientation

~78% of sales

Significant international business

Majority exports (Europe, SE Asia)

Company Snapshot

$10M

Revenue

48

Employees

1991

Founded

District Ahmedabad, India

Headquarters

SWOT Analysis

Strengths

  • Long operating record: Incorporated 1991, >25 years of operations recognised by CARE as a rating strength (Dec 2025).
  • Export franchise: Exports at 78% of gross sales (₹59.59 Cr) in FY2025, up from ~75% in FY2023 (CARE), across at least seven countries.
  • Design breadth: >600 decors and >50 textures (FY2025 directors' report), comparable to far larger peers.
  • Consistent profitability: Positive annual net profit in every year from FY2008 to FY2026 (Pocketful; Screener), including through the GFC and COVID.
  • Improving working capital: Cash conversion cycle reduced from 155 days (FY2023) to 102 days (FY2026) (Screener).
  • Stable promoter commitment: 71.12% promoter holding unchanged since FY2019 with no pledging disclosed; history of promoter unsecured loans supporting liquidity (Screener; related-party note Sep 2020).

Weaknesses

  • Thin margins: EBITDA margin of 4.78% in FY2026 vs ~18–19% at export peer Stylam (Screener; FilingReader).
  • Flat absolute EBITDA: ₹4.0–4.4 Cr in each of FY2022–FY2026 despite revenue rising from ₹64.6 Cr to ₹86.6 Cr (Screener).
  • Earnings dependent on FX: Other income (largely FX gains) of ₹1.94 Cr = 76% of FY2026 PBT (Screener; S&P).
  • Sub-par returns: ROE 6.4–9.2% over FY2022–FY2026; 3-year average ~7.4% (Screener).
  • Weak coverage: CARE PBILDT interest coverage 2.59x (FY2025), 2.40x (H1 FY2026) — below CARE's 2.5x downgrade sensitivity.
  • Scale: Capacity unchanged at 21 lakh sheets p.a. since at least 2019 (CARE Dec 2019 and Dec 2025); no disclosed expansion plan.

Opportunities

  • Revenue momentum: Q1 FY2027 sales of ₹29.72 Cr (+51.7% YoY) and TTM revenue of ₹96.8 Cr (+23%) (Screener).
  • Global compact HPL growth: Compact HPL market growing ~4.2% CAGR to USD 1.06 bn by 2032 (24ChemicalResearch); Alfa already offers cubicle and colour compacts.
  • Industry price increases: Leaders passed through 12–15% laminate price hikes in FY2026 (Greenlam commentary via HDFC Sky), creating room for realisation gains.
  • Domestic market expansion: Domestic share only ~22% of sales; India decorative laminates market growing ~4.6–5.4% CAGR (IMARC; Mordor).
  • Rating upgrade pathway: CARE upgrade triggers (PBILDT margin >10%, net worth >₹75 Cr) are explicit (CARE Dec 2025).
  • Operating leverage: With fixed assets of ₹19.9 Cr generating ₹86.6 Cr revenue (asset turnover 1.71x), utilisation gains could lift margins if cost discipline holds.

Threats

  • Customer insolvency: UK distributor International Decorative Surfaces in administration — ₹2.68 Cr receivable, ~60% written off (CARE Dec 2025).
  • Raw-material volatility: ~40% of raw material cost imported (papers, melamine); prices volatile (CARE Dec 2025).
  • Currency reversal: No active hedging; rupee appreciation would cut both realisations and the FX gains supporting profit (CARE).
  • Intensifying competition: Stylam adding a third plant (operations from mid-2026) and Greenlam expanding laminates volumes 7–8% p.a. (FilingReader; HDFC Sky).
  • Geopolitical exposure: Sales to Russia and Israel named among key markets (CARE) — sanctions, banking and conflict risk.
  • Rating downgrade risk: Interest coverage already below the 2.5x trigger; operating cycle had exceeded the 125-day trigger in FY2023–FY2025 on Screener's measure (CARE methodology differs).

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
28–29 May 2025Q4/FY2025 results: Q4 sales ₹20.37 Cr (+10.8%), NP ₹1.08 Cr (+80%); FY2025 sales ₹78.56 Cr (+14.7%), NP ₹1.44 Cr (−14.3%)Revenue recovery but lower full-year profit after Q3 write-off
29 May 2025Newspaper publication of results (Reg. 30/47)Compliance
19 Jul 2025Newspaper publication (Reg. 30)Compliance
8 Aug 2025Q1 FY2026 results: sales ₹19.59 Cr (+0.4%), NP ₹0.50 Cr (+19%)Flat volumes
10 Aug 2025Newspaper publication of Q1 resultsCompliance
23 Aug 2025Board approves re-designation of Rishi Tikmani as MD and Pooja Tikmani as Women JMD (1 Oct 2025 – 30 Sep 2028); approves AGM notice; record/cut-off date 19 Sep 2025Leadership formalisation
5 Sep 2025Newspaper publication of AGM noticeCompliance
Late Sep 202534th AGM (FY2025 accounts; re-appointment of Pooja Tikmani by rotation)Governance
30 Sep 2025Resignation of CS Himadri Trivedi and appointment of new CS & Compliance OfficerKMP change
1 Oct 2025MD/JMD designations take effectGovernance
8 Nov 2025Q2 FY2026 results: sales ₹18.98 Cr (+3.0%), NP ₹0.45 Cr (−6.3%); operating profit −17.7%Margin pressure
26 Nov 2025Newspaper publicationCompliance
16 Dec 2025CARE reaffirms BBB; Stable / A3; discloses ₹2.68 Cr receivable from UK-based International Decorative Surfaces (in administration), ~60% written off; ₹0.34 Cr overdue from a US entityCredit and customer-concentration risk crystallised
Oct–Dec 2025Shareholder count falls from 5,665 to 3,172Unexplained register change
24 Dec 2025Stock closes ₹86.00 (+7.5% on day)Price volatility
9 Jan 2026Reg. 74(5) SEBI (DP) certificate filed for Q3Compliance
18 Jan 2026Shareholding pattern Dec 2025: promoters 71.12%No change
28–30 Jan 2026Board meeting intimation and trading-window closureRoutine
5 Feb 2026Q3 FY2026 results: sales ₹22.17 Cr (+9.45%), NP ₹0.39 Cr vs loss of ₹0.54 Cr in Q3 FY2025 (one source cites board date as 6 Feb 2026)Return to growth
11 Feb 2026Newspaper publication of Q3 resultsCompliance
20 Feb 2026Stock hits 10% upper circuit to ₹82.39Thin-float volatility
19–20 May 2026FY2026 results: revenue ₹86.64 Cr (+10.3%), NP ₹1.90 Cr (+32%); Q4 sales ₹25.90 Cr (+27%) but OPM 1.97%Record revenue; FX-aided profit
22 & 29 May 2026Newspaper publications of resultsCompliance
25 Jun 2026Trading-window closure ahead of Q1Routine
8 Aug 2026Q1 FY2027 results: sales ₹29.72 Cr (+51.7%), NP ₹0.77 Cr (+54%), OPM 5.08%Record quarterly revenue
11 Aug 2026Stock rises to ₹87.36 (+4.8%) post-resultsMarket reaction
28 Aug 2026Newspaper publication of 35th AGM noticeCompliance
21 Sep 202635th AGM: FY2026 accounts adopted; Shyamal Raval re-appointed; MD and JMD remuneration increases effective 1 Aug 2026 approvedGovernance; rising management cost
23 Sep 2026Scrutiniser's report on AGM voting filedCompliance
24 Sep 2026Intimation of 3 Oct 2026 board meeting to consider CS resignation (Dhara Mistry) and appointment (Himandri Shah)Second CS turnover in a year
27 Sep 2026Trading-window closure for Q2 FY2027Routine
c. 3–4 Oct 2026Updated contact details of new CS & Compliance Officer filedCompliance
16 Oct 2026Stock closes ₹70.10 (−4.8%), near 52-week low of ₹67.8Sentiment weak despite Q1 growth

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

4 charts
Income Statement: Revenue & Gross Profit: Revenue from operations rose from INR 799.8 Mn in FY2022 to INR 866.4 Mn in FY2026.
Alfa Ica (India) Limited — Income Statement: Revenue & Gross Profit
Series (INR Mn)FY2022FY2023FY2024FY2025FY2026
Revenue from operations799.8646.4684.9785.6866.4
Gross profit – S&P definition287.4239.1261.8318.6334.7

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Sources

Sources

  1. BSE Limited filings: Annual Reports 2008-09, 2009-10, 2010-11, 2011-12, 2018-19; Board outcome 23 Aug 2025; related-party disclosure (Dec 2020); AGM and board intimations 2026 (via Screener.in, Business Standard media, Investywise, ScanX).
  2. CARE Ratings press releases: Alfa Ica (India) Limited, 31 Dec 2019 and 16 Dec 2025.
  3. Screener.in — Alfa Ica (India) Ltd standalone financials, ratios, shareholding and announcements (data by C-MOTS), accessed Oct 2026.
  4. StockAnalysis.com — Alfa Ica (India) income statement (S&P Global Market Intelligence), updated 8 Aug 2026; Greenlam Industries income statement.
  5. Simply Wall St — Alfa Ica (India) stock report, management and company information (S&P Global).
  6. Business Standard / Capital Market–Live News — FY2025 results (29 May 2025); share price pages.
  7. JM Financial / Capital Market — Q1 FY2027 results (8 Aug 2026); ScanX; Univest.
  8. Emkay Global (Dion Global) — Q2 FY2026 results (8 Nov 2025).
  9. IIFL (indiainfoline.com) — Directors' Report FY2025 extracts; company summary.
  10. Kotak Securities, Kotak Neo, Groww, Investing.com, BFSL/Vogue, ICICI Direct, Bajaj Broking, MarketsMojo, Anand Rathi, Fyers, IndMoney, Pocketful, Panjiva — company profiles and market data.
  11. Greenlam Industries — Q4 FY2026 press release (22 May 2026); Construction World; Trendlyne; HDFC Sky (Prime Research, 27 May 2026); ScanX.
  12. Stylam Industries — FilingReader (7 May 2026; 22 Jul 2026; 2 Aug 2025); Fyers; Kotak Neo; AlphaStreet.
  13. IMARC Group — India Decorative Laminates Market (2025, 2026 editions); India Laminates Market.
  14. Mordor Intelligence (via GII) — India Decorative Laminates Market 2026–2031.
  15. SkyQuest (via GII) — Global Decorative HPL Market; 24ChemicalResearch (via CB Insights/EINPresswire) — Compact HPL Market.
  16. Ply Reporter — Business Scope of 1.25 mm Decorative Laminate (Oct 2025).
  17. Legal Suvidha — Company Secretary changes roundup (4 Oct 2026).

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.